MetrioPharm AG
MetrioPharm AG is a clinical stage biotech company focused on therapies for inflammatory and infectious diseases. MP1032 represents a novel concept in anti-inflammatory and corticosteroid-sparing/replacement therapy. As a monotherapy, MP1032 produces therapeutic effects similar to corticosteroids (cortisone-based therapeutics), - but without steroid associated side effects that continue to burden patients across multiple indications.
Date, time and room information
Monday, May 4, 17:45 - 18:00, room Montreal
Category
Clinical stage development company
Title of the presentation
MP1032 - First-In-Class Immunomodulator for Treatment of Inflammatory & Infectious Diseases - Similar Efficacy to Corticosteroids but No Steroid-Associated Side Effects
Speaker information
| Name | Position | Institution |
|---|---|---|
| Thomas Christely | CEO | MetrioPharm AG |
Host and event manager:
Logistics and marketing partner:
